Onychomycosis Treatment Market Research and Forecast Report 2023-2028

1. Global Onychomycosis Treatment Market Research and Forecast Report 2023-2028 Author: Elena Anderson Marketing Manager Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2022 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Onychomycosis Treatment Market Research Report 2023-2028: The latest report by IMARC Group, titled “Onychomycosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028,” finds that the global onychomycosis treatment market reached a value of US$ 3.1 Billion in 2022. Onychomycosis is a fungal infection that occurs in the fingernails and toenails, resulting in discomfort, discoloration, chronic pain, and disfigurement. It is a common nail infection in patients with athlete’s feet and is caused by various organisms, such as dermatophytes, yeasts, and non- dermatophyte molds. It is usually diagnosed through oxygen and hydrogen (KOH) examination, potassium, culture, and histopathological examinations of nail clippings and nail biopsies and is treated through laser therapy, drugs, and photodynamic therapies. Request for a PDF sample of this report: https://www.imarcgroup.com/onychomycosis-treatment- market/requestsample

4. Report Description and Highlights Report Description Global Onychomycosis Treatment Market Trends: The market is primarily driven by the rising prevalence of chronic medical ailments, such as onychomycosis, human immunodeficiency virus (HIV), diabetes, and peripheral artery disease (PAD) among the masses. In addition, the development of water-soluble antifungal treatment solutions that can be administered orally and aid in preventing secondary bacterial infections and the growth of fungus represents another major growth-inducing factor. Besides this, onychomycosis is highly prevalent among millennials and adults due to the increased exposure to public swimming pools and utilization of tight, contaminated, or soiled clothes, shoes, and socks. This, coupled with the rising popularity of topical nail lacquers and ointments to maintain nail hygiene, is contributing to the market growth. Moreover, the developing healthcare infrastructure across the globe is also creating a favorable market outlook. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a CAGR of 5.37% during the forecast (2023-2028). View Report TOC, Figures and Tables: https://www.imarcgroup.com/onychomycosis-treatment- market

5. Report Description and Highlights Report Description Key Market Segmentation The research report includes the following segments: Breakup by Disease Type: •Distal Subungual Onychomycosis •Proximal Subungual Onychomycosis •White Superficial Onychomycosis •Candidal Onychomycosis •Others Breakup by Treatment Type: •Laser Therapy •Photodynamic Therapy •Drug Treatment Breakup by Drug Class: •Allylamine •Azole •Griseofulvin •Others

6. Report Description and Highlights Report Description Breakup by Distribution Channel: •Hospitals and Clinics •Online Stores •Retail Pharmacies •Others Breakup by Region: •North America •Asia Pacific •Europe •Latin America •Middle East and Africa

7. Report Description and Highlights Report Description Competitive Landscape with Key Players: •Bausch Health Companies Inc. •Cipla Limited •Dr. Reddy's Laboratories •Galderma SA •GlaxoSmithKline PLC •Kaken Pharmaceutical Co. Ltd •Lumenis Ltd •Moberg Pharma AB •Novartis AG •Pfizer Inc. •The OTC Lab B.V.

8. Key Questions Answered in the Report Report Description 1. 2. What was the size of the global onychomycosis treatment market in 2022? What is the expected growth rate of the global onychomycosis treatment market during 2023- 2028? What are the key factors driving the global onychomycosis treatment market? What has been the impact of COVID-19 on the global onychomycosis treatment market? What is the breakup of the global onychomycosis treatment market based on the disease type? What is the breakup of the global onychomycosis treatment market based on the treatment type? What is the breakup of the global onychomycosis treatment market based on the distribution channel? What are the key regions in the global onychomycosis treatment market? Who are the key players/companies in the global onychomycosis treatment market? 3. 4. 5. 6. 7. 8. 9.

9. Report DescriptionTable of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Onychomycosis Treatment Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast

10. Report DescriptionTable of Contents 6 Market Breakup by Disease Type 6.1 Distal Subungual Onychomycosis 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Proximal Subungual Onychomycosis 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 White Superficial Onychomycosis 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Candidal Onychomycosis 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Others 6.5.1 Market Trends 6.5.2 Market Forecast 7 Market Breakup by Treatment Type Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/onychomycosis-treatment-market/toc

11. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

12. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

13. Report Description and Highlights Report Description © 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

14. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com